Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker STOK
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 200 | $26.99 | $5,398 Sale | Form 4 ↗ |
| Nov 2, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 6,995 | $26.38 | $184.5K Sale | Form 4 ↗ |
| Sep 1, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 1,600 | $31.06 | $49.7K Sale | Form 4 ↗ |
| Sep 1, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 3,945 | $30.51 | $120.4K Sale | Form 4 ↗ |
| Aug 18, 2026 | Jonathan Allan GENERAL COUNSEL & CORP SEC | STOK Stoke Therapeutics, Inc. | Sale | 145 | $32.47 | $4,708 Sale | Form 4 ↗ |
| Aug 18, 2026 | Jonathan Allan GENERAL COUNSEL & CORP SEC | STOK Stoke Therapeutics, Inc. | Sale | 2,716 | $32.01 | $86.9K Sale | Form 4 ↗ |
| Aug 18, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 242 | $32.47 | $7,858 Sale | Form 4 ↗ |
| Aug 18, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 4,525 | $32.01 | $144.8K Sale | Form 4 ↗ |
| Aug 18, 2026 | Edward M. Kaye MD Director | STOK Stoke Therapeutics, Inc. | Sale | 637 | $32.47 | $20.7K Sale | Form 4 ↗ |
| Aug 18, 2026 | Edward M. Kaye MD Director | STOK Stoke Therapeutics, Inc. | Sale | 11,930 | $32.01 | $381.9K Sale | Form 4 ↗ |
| Aug 3, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 1,269 | $29.45 | $37.4K Sale | Form 4 ↗ |
| Aug 3, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 5,907 | $28.95 | $171.0K Sale | Form 4 ↗ |
| Jul 1, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 500 | $33.27 | $16.6K Sale | Form 4 ↗ |
| Jul 1, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 6,728 | $32.62 | $219.5K Sale | Form 4 ↗ |
| Jun 16, 2026 | Jonathan Allan GENERAL COUNSEL & CORP SEC | STOK Stoke Therapeutics, Inc. | Sale | 1,457 | $29.95 | $43.6K Sale | Form 4 ↗ |
| Jun 1, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 1,795 | $30.58 | $54.9K Sale | Form 4 ↗ |
| May 1, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 2,243 | $32.79 | $73.5K Sale | Form 4 ↗ |
| Apr 1, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 1,838 | $32.66 | $60.0K Sale | Form 4 ↗ |
| Mar 20, 2026 | Jonathan Allan GENERAL COUNSEL & CORP SEC | STOK Stoke Therapeutics, Inc. | Sale | 601 | $34.41 | $20.7K Sale | Form 4 ↗ |
| Mar 20, 2026 | Jonathan Allan GENERAL COUNSEL & CORP SEC | STOK Stoke Therapeutics, Inc. | Sale | 8,692 | $33.64 | $292.4K Sale | Form 4 ↗ |
| Mar 19, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 1,461 | $29.99 | $43.8K Sale | Form 4 ↗ |
| Mar 18, 2026 | Jonathan Allan GENERAL COUNSEL & CORP SEC | STOK Stoke Therapeutics, Inc. | Sale | 72 | $32.85 | $2,365 Sale | Form 4 ↗ |
| Mar 18, 2026 | Jonathan Allan GENERAL COUNSEL & CORP SEC | STOK Stoke Therapeutics, Inc. | Sale | 334 | $31.79 | $10.6K Sale | Form 4 ↗ |
| Mar 18, 2026 | Jonathan Allan GENERAL COUNSEL & CORP SEC | STOK Stoke Therapeutics, Inc. | Sale | 4,222 | $31.28 | $132.1K Sale | Form 4 ↗ |
| Mar 18, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 103 | $32.85 | $3,384 Sale | Form 4 ↗ |
| Mar 18, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 483 | $31.79 | $15.4K Sale | Form 4 ↗ |
| Mar 18, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 6,100 | $31.28 | $190.8K Sale | Form 4 ↗ |
| Mar 18, 2026 | Thomas Leggett Chief Financial Officer | STOK Stoke Therapeutics, Inc. | Sale | 37 | $32.85 | $1,215 Sale | Form 4 ↗ |
| Mar 18, 2026 | Thomas Leggett Chief Financial Officer | STOK Stoke Therapeutics, Inc. | Sale | 172 | $31.79 | $5,468 Sale | Form 4 ↗ |
| Mar 18, 2026 | Thomas Leggett Chief Financial Officer | STOK Stoke Therapeutics, Inc. | Sale | 2,173 | $31.28 | $68.0K Sale | Form 4 ↗ |
| Mar 18, 2026 | Jason Hoitt Chief Patient Officer | STOK Stoke Therapeutics, Inc. | Sale | 30 | $32.85 | $986 Sale | Form 4 ↗ |
| Mar 18, 2026 | Jason Hoitt Chief Patient Officer | STOK Stoke Therapeutics, Inc. | Sale | 139 | $31.79 | $4,419 Sale | Form 4 ↗ |
| Mar 18, 2026 | Jason Hoitt Chief Patient Officer | STOK Stoke Therapeutics, Inc. | Sale | 1,762 | $31.28 | $55.1K Sale | Form 4 ↗ |
| Mar 17, 2026 | Jonathan Allan GENERAL COUNSEL & CORP SEC | STOK Stoke Therapeutics, Inc. | Sale | 1,791 | $33.38 | $59.8K Sale | Form 4 ↗ |
| Mar 17, 2026 | Jonathan Allan GENERAL COUNSEL & CORP SEC | STOK Stoke Therapeutics, Inc. | Sale | 2,476 | $32.74 | $81.1K Sale | Form 4 ↗ |
| Mar 17, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 2,587 | $33.38 | $86.4K Sale | Form 4 ↗ |
| Mar 17, 2026 | Barry Ticho CHIEF MEDICAL OFFICER | STOK Stoke Therapeutics, Inc. | Sale | 3,577 | $32.74 | $117.1K Sale | Form 4 ↗ |
| Mar 17, 2026 | Thomas Leggett Chief Financial Officer | STOK Stoke Therapeutics, Inc. | Sale | 922 | $33.38 | $30.8K Sale | Form 4 ↗ |
| Mar 17, 2026 | Thomas Leggett Chief Financial Officer | STOK Stoke Therapeutics, Inc. | Sale | 1,274 | $32.74 | $41.7K Sale | Form 4 ↗ |
| Mar 17, 2026 | Jason Hoitt Chief Patient Officer | STOK Stoke Therapeutics, Inc. | Sale | 748 | $33.38 | $25.0K Sale | Form 4 ↗ |
| Mar 17, 2026 | Jason Hoitt Chief Patient Officer | STOK Stoke Therapeutics, Inc. | Sale | 1,033 | $32.74 | $33.8K Sale | Form 4 ↗ |
| Mar 13, 2026 | Arthur A. Levin Director | STOK Stoke Therapeutics, Inc. | Sale | 605 | $36.80 | $22.3K Sale | Form 4 ↗ |
| Mar 10, 2026 | Adrian R. Krainer Director | STOK Stoke Therapeutics, Inc. | Sale | 33,243 | $39.74 | $1.3M Sale | Form 4 ↗ |
| Mar 10, 2026 | Arthur Tzianabos Interim Executive Chair, Director | STOK Stoke Therapeutics, Inc. | Sale | 4,355 | $40.00 | $174.2K Sale | Form 4 ↗ |
| Mar 2, 2026 | Adrian R. Krainer Director | STOK Stoke Therapeutics, Inc. | Sale | 7,229 | $39.66 | $286.7K Sale | Form 4 ↗ |
| Dec 8, 2025 | Jonathan Allan GENERAL COUNSEL & CORP SEC | STOK Stoke Therapeutics, Inc. | Sale | 2,678 | $32.61 | $87.3K Sale | Form 4 ↗ |
| Dec 8, 2025 | Jonathan Allan GENERAL COUNSEL & CORP SEC | STOK Stoke Therapeutics, Inc. | Sale | 1,300 | $31.60 | $41.1K Sale | Form 4 ↗ |
| Dec 8, 2025 | Edward M. Kaye MD Director | STOK Stoke Therapeutics, Inc. | Sale | 1,331 | $33.10 | $44.1K Sale | Form 4 ↗ |
| Dec 8, 2025 | Edward M. Kaye MD Director | STOK Stoke Therapeutics, Inc. | Sale | 8,274 | $32.52 | $269.1K Sale | Form 4 ↗ |
| Dec 8, 2025 | Edward M. Kaye MD Director | STOK Stoke Therapeutics, Inc. | Sale | 3,825 | $31.44 | $120.3K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:38 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances